Ethyl 1-isopropyl-3-methyl-1H-1,2,4-triazole-5-carboxylate, 97%, 250mg

(S)-2-((S)-2-Amino-3-(1H-indol-3-yl)propanamido)-4-(trimethylsilyl)butanoic acid hydrochloride, 97%, 25mg

6-Chloro-1H-benzo[d]imidazole-2-carboxylic acid, 95.0%, 250mg

3-(4-Fluorophenoxy)propionic acid, 97.0%, 5g

2,6-Bis(benzyloxy)-3-(4-bromo-2,6-difluorophenyl)pyridine, 98%, 250mg

1-AZETIDIN-1-YL-2-CHLORO-ETHANONE, 95.0%, 5g

2-Bromo-6-methoxyisonicotinic acid, 95.0%, 5g

4-Iodoquinoline, 95.0%, 5g

Neopentylamine, 95.0%, 10g

5-Bromo-2-methylbenzoic acid, 97.0%, 25g

4,5,6-Trifluoropyrimidine, 96.0%, 1g

(2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95.0%, 5g

(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg